These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2042398)

  • 1. Simultaneous expression of the Lassa virus N and GPC genes from a single recombinant vaccinia virus.
    Morrison HG; Goldsmith CS; Regnery HL; Auperin DD
    Virus Res; 1991 Mar; 18(2-3):231-41. PubMed ID: 2042398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus.
    Morrison HG; Bauer SP; Lange JV; Esposito JJ; McCormick JB; Auperin DD
    Virology; 1989 Jul; 171(1):179-88. PubMed ID: 2741340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection.
    Auperin DD; Esposito JJ; Lange JV; Bauer SP; Knight J; Sasso DR; McCormick JB
    Virus Res; 1988 Feb; 9(2-3):233-48. PubMed ID: 3354260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and cellular localisation of porcine transmissible gastroenteritis virus N and M proteins by recombinant vaccinia viruses.
    Pulford DJ; Britton P
    Virus Res; 1991 Mar; 18(2-3):203-17. PubMed ID: 1645905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene.
    Fisher-Hoch SP; McCormick JB; Auperin D; Brown BG; Castor M; Perez G; Ruo S; Conaty A; Brammer L; Bauer S
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):317-21. PubMed ID: 2911575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baculovirus expression of the glycoprotein gene of Lassa virus and characterization of the recombinant protein.
    Hummel KB; Martin ML; Auperin DD
    Virus Res; 1992 Sep; 25(1-2):79-90. PubMed ID: 1413995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses.
    Romero CH; Barrett T; Chamberlain RW; Kitching RP; Fleming M; Black DN
    Virology; 1994 Oct; 204(1):425-9. PubMed ID: 8091673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the Lassa virus nucleocapsid protein in insect cells infected with a recombinant baculovirus: application to diagnostic assays for Lassa virus infection.
    Barber GN; Clegg JC; Lloyd G
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():19-28. PubMed ID: 2406367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein.
    ter Meulen J; Badusche M; Kuhnt K; Doetze A; Satoguina J; Marti T; Loeliger C; Koulemou K; Koivogui L; Schmitz H; Fleischer B; Hoerauf A
    J Virol; 2000 Mar; 74(5):2186-92. PubMed ID: 10666248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinia virus recombinants expressing rabiesvirus glycoprotein protect against rabies.
    Esposito J; Brechling K; Baer G; Moss B
    Virus Genes; 1987 Nov; 1(1):7-21. PubMed ID: 3508340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus.
    Yasuda A; Kimura-Kuroda J; Ogimoto M; Miyamoto M; Sata T; Sato T; Takamura C; Kurata T; Kojima A; Yasui K
    J Virol; 1990 Jun; 64(6):2788-95. PubMed ID: 2159544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of envelope glycoprotein (E) of Japanese encephalitis virus by recombinant vaccinia virus.
    Haishi S; Imai H; Hirai K; Igarashi A; Kato S
    Acta Virol; 1989 Dec; 33(6):497-503. PubMed ID: 2576591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.
    Saijo M; Georges-Courbot MC; Marianneau P; Romanowski V; Fukushi S; Mizutani T; Georges AJ; Kurata T; Kurane I; Morikawa S
    Clin Vaccine Immunol; 2007 Sep; 14(9):1182-9. PubMed ID: 17634509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of feline immunodeficiency virus (FIV) gag gene in vaccinia virus vector.
    Wojcik J
    Acta Microbiol Pol; 1995; 44(2):191-6. PubMed ID: 8906935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vaccine based on recombinant modified Vaccinia Ankara containing the nucleoprotein from Lassa virus protects against disease progression in a guinea pig model.
    Kennedy EM; Dowall SD; Salguero FJ; Yeates P; Aram M; Hewson R
    Vaccine; 2019 Aug; 37(36):5404-5413. PubMed ID: 31331770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinia virus: a selectable eukaryotic cloning and expression vector.
    Mackett M; Smith GL; Moss B
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7415-9. PubMed ID: 6296831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice.
    Wild TF; Bernard A; Spehner D; Drillien R
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():359-67. PubMed ID: 1538193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One hundred base pairs of 5' flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription.
    Bertholet C; Drillien R; Wittek R
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2096-100. PubMed ID: 3856886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection.
    Mason PW; Pincus S; Fournier MJ; Mason TL; Shope RE; Paoletti E
    Virology; 1991 Jan; 180(1):294-305. PubMed ID: 1845826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.